Zawitz David
SEC insider (Form 3/4/5 filer). CIK 0002046750. Chief Operating Officer at Verrica Pharmaceuticals Inc. (VRCA). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in WEST CHESTER, PA.
Companies Zawitz David has filed insider reports for
- Verrica Pharmaceuticals Inc. (VRCA): Officer, Chief Operating Officer
Zawitz David
CIK: 0002046750
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Verrica Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 17, 2026VRCA
Verrica Pharmaceuticals Inc.
PurchaseDirect6K shares at avg. $4.98$30K - Jun 5, 2026VRCA
Verrica Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (right to buy)
171.3K shares- - Nov 25, 2025VRCA
Verrica Pharmaceuticals Inc.
PurchaseDirect10K shares at avg. $4.24$42K - Dec 9, 2024VRCA
Verrica Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (right to buy)
950K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 | VRCA Verrica Pharmaceuticals Inc. | Purchase | 6,000 | $4.98 | $29,880 | Direct |
| Jun 5, 2026 | VRCA Verrica Pharmaceuticals Inc. | Award Employee Stock Option (right to buy) | 171,340 | - | - | Direct |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc. | Purchase | 10,000 | $4.24 | $42,425 | Direct |
| Dec 9, 2024 | VRCA Verrica Pharmaceuticals Inc. | Award Employee Stock Option (right to buy) | 950,000 | - | - | Direct |
1-4 of 4 transactions